Sector: Pharmaceuticals & Biotechnology

Small Cap

Valiant Laboratories Share Price

VALIANTLAB

₹100.52

4.78(4.99%)

24th Aug 2026 | 3:07 PM

NSE : VALIANTLAB

Open Free Demat Account

Valiant Laboratories Performance

Price Movement

₹100.52

₹97.21

₹100.52

↘ Today's Low↗ Today's High

1 Year Performance

₹100.52

₹49.51

₹96.24

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹100.52

Low₹97.21

Open at₹97.90

Prev Close₹95.74

Volumes1.75 L

Avg Price₹100.17

Lower Circuit₹90.96

Upper Circuit₹100.52

Historical Performance

3M High₹96.24

3M Low₹58.08

1 Yr High₹96.24

1 Yr Low₹49.51

3 Yr High₹199.64

3 Yr Low₹49.51

5 Yr High₹199.64

5 Yr Low₹49.51

Summary

As of 25-08-2026 00:51, Valiant Laboratories Ltd. share price today is ₹0, with a change of ₹-95.74 (-100.00%) from the previous close of ₹95.74. The stock opened at ₹97.9 and traded between ₹97.21 and ₹100.52, with a total traded volume of 174713 shares. The company has a market capitalization of ₹520 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹96.24 and ₹49.51, respectively.

Valiant Laboratories Ltd. valuation metrics include a P/E ratio of 32.5, EPS of ₹-0.51, and book value of ₹1.60. Profitability indicators show ROE of -1.05%. Valiant Laboratories Ltd. has reported revenue of ₹305.93 Cr and net profit of ₹16.01 Cr.

Valiant Laboratories Ltd. technical indicators include Day RSI at 89.52, Day MFI at 99.81, Day ADX at 53.44. Additional indicators include Commodity Channel Index (CCI) at 131.7 and Williams %R at -1.38. Momentum indicators show Day MACD at 7.52, Day MACD Signal Line at 4.41, DayATR at 3.89. Rate of Change indicators for Valiant Laboratories Ltd. include ROC125 at 61.86 and ROC21 at 53.77.

Exponential moving averages include EMA5 at ₹90.6, EMA10 at ₹84.4, EMA12 at ₹82.5, EMA20 at ₹77.2, EMA26 at ₹75, EMA50 at ₹71.3, EMA100 at ₹69.7, EMA200 at ₹71.8. Simple moving averages include SMA5 at ₹91.4, SMA10 at ₹83.1, SMA20 at ₹72.4, SMA30 at ₹69.3, SMA50 at ₹68, SMA100 at ₹69.8, SMA150 at ₹66, SMA200 at ₹67.6.

Support levels for Valiant Laboratories are placed at First Support ₹92.37, Second Support ₹89.01, Third Support ₹87.07. Resistance levels are seen at First Resistance ₹97.67, Second Resistance ₹99.61, Third Resistance ₹102.97. Valiant Laboratories Ltd. shareholding pattern shows promoter holding at 74.94%, FII holding at 0%, DII holding at 0%, public holding at 25.06%.

Valiant Laboratories Fundamentals

Market Cap

Above industry Median

520 Cr.

PE Ratio (TTM)

Above industry Median

32.50

Dividend Yield

Net Profit TTM

12215.4% incr over last year

16.01

Net Profit Growth

12215.4% incr over last year

16.01

PEG Ratio

Below industry Median

ROE

13% decr over last year

-1.05

Operating Revenue TTM

305.93

Operating Revenue Growth

89.6% incr over last year

Book Value

Below industry Median

1.60

MFI

MFI strongly Overbought

99.81

RSI

RSI strongly Overbought

89.52

EPS (TTM)

-0.51

Debt to Equity

0.14

Face Value

Operating Profit Margin Qtr.

2.66

Operating Profit Qtr.

29.26

Net Profit Qtr.

21.10

Operating Revenue Qtr.

115.29

PB Ratio

1.60

Valiant Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	73.42	65.30	54.74	45.99	51.01
Operating Expense	60.92	60.80	54.49	45.93	48.65
Operating Profit	12.50	4.50	0.25	0.06	2.36
Depreciation	0.55	0.52	0.72	0.51	0.51
Interest	0.08	0.02	0.03	0.14	0.07
Tax	3.25	1.20	0.08	0.09	0.63
Net Profit	9.48	3.53	0.03	0.17	1.82

Valiant Laboratories Technicals

Valiant Laboratories Ltd. EMA & SMA

₹100.52

8.86 (9.67%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹90.6

Day EMA10 ₹84.4

Day EMA12 ₹82.5

Day EMA20 ₹77.2

Day EMA26 ₹75

Day EMA50 ₹71.3

Day EMA100 ₹69.7

Day EMA200 ₹71.8

Valiant Laboratories Support and Resistance

Resistance

First Resistance₹97.67

Second Resistance₹99.61

Third Resistance₹102.97

Support

First Support₹92.37

Second Support₹89.01

Third Support₹87.07

Technical Indicators

Day RSI89.52

Day MFI99.81

Day ADX53.44

Day Commodity Channel Index131.70

William-1.38

Day MACD7.52

Day MACD Signal Line4.41

Day ATR3.89

Day ROC12561.86

Day ROC2153.77

Valiant Laboratories Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	74.9	74.9	74.9	74.9	74.9	74.9
FII	0.6	0.6	0	0	0.2	0
DII	0	0.5	0	0	0	0
Public	24.4	24	25	25	24.9	25.1

Valiant Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2.91 L	3.74 L	77.79%
Week	3.43 L	4.62 L	74.21%
1 Month	96.43 K	1.24 L	78.07%
6 Month	53.31 K	72.03 K	74.01%

Valiant Laboratories SWOT Analysis

Strengths27

Weakness6

Opportunity0

Threats0

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

DVM Performers for All Stocks (weekly, higher risk) - subscription

Relative Outperformance versus Industry over 1 Month

Companies with high TTM EPS Growth

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

New 52 week high today

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Increasing profits every quarter for the past 2 quarters

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Stock gained more than 20% in one month

Top Gainers

New 52 Week High

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Valiant Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Valiant Laboratories Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.
Price (₹)	₹526.25	₹6.55	₹205.20	₹15.46	₹518.70
% Change	-2.70%	4.97%	4.81%	8.26%	-3.29%
Revenue TTM (₹ Cr)	₹526.28	₹69.99	₹291.17	₹226.23	₹511.48
Net Profit TTM (₹ Cr)	₹20.77	₹-176.47	₹14.68	₹31.63	₹53.97
PE TTM	115.10	-0.30	51.80	2.40	28.70
1 Year Return	37.97	524	55.39	56.92	-23.59
ROCE	3.56	-56.37	-	17.36	23.87

Similar Stocks

SIGACHI

Sigachi Industries Ltd.

₹ 30.45

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 988.00

-0.56%

VINEETLAB

Vineet Laboratories Ltd.

₹ 37.00

-2.14%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 628.00

+1.80%

ZIMLAB

Zim Laboratories Ltd.

₹ 124.16

-0.70%

MEDICO

Medico Remedies Ltd.

₹ 42.09

-1.31%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 173.00

-0.31%

LASA

Lasa Supergenerics Ltd.

₹ 7.33

+1.81%

HALEOSLABS

Haleos Labs Ltd.

₹ 1500.00

+2.39%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 302.20

+0.73%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 322.00

+0.00%

ORTINGLOBE

Ortin Global Ltd.

₹ 15.26

-3.96%

BROOKS

Brooks Laboratories Ltd.

₹ 61.70

+2.83%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2638.00

+0.05%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 254.55

+4.99%

ALPA

Alpa Laboratories Ltd.

₹ 61.20

-2.47%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 354.00

-0.73%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.80

+3.15%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 30.44

+9.97%

INDOCO

Indoco Remedies Ltd.

₹ 220.00

-2.78%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 325.35

-1.29%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 612.00

-0.33%

PANACEABIO

Panacea Biotec Ltd.

₹ 406.50

-1.12%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 234.00

-4.31%

THEMISMED

Themis Medicare Ltd.

₹ 120.50

+13.53%

FAQ's on VALIANTLAB

What is the current share price of Valiant Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Valiant Laboratories Ltd. is ₹ 100.52 on the NSE and ₹ 100.49 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Valiant Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Valiant Laboratories Ltd. is approximately ₹ 520 Cr.

What are the PE and PB ratios for Valiant Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Valiant Laboratories Ltd. is 32.5, and the Price-to-Book (PB) ratio is 1.6.

What is the 52-Week High and Low for Valiant Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Valiant Laboratories Ltd. shares was ₹ 96.24, and the lowest price was ₹ 49.51.

Who are the major shareholders of Valiant Laboratories Ltd.?

Significant shareholdings in Valiant Laboratories Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Valiant Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Valiant Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy